Rituximab Versus Tocilizumab in Anti-Tnf Inadequate Responder Patients with Rheumatoid Arthritis (R4RA): a Stratified, Biopsy-Driven, Multi-Centre, Randomised, Open Label, Controlled Clinical Trial – 16 Week Outcomes
Lancet(2020)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined